Literature DB >> 17481663

Neuropsychological and 18FDG-PET studies in a family with idiopathic basal ganglia calcifications.

Isabelle Le Ber1, Rose-Marie Marié, Benoît Chabot, Catherine Lalevée, Gilles-Louis Defer.   

Abstract

Idiopathic basal ganglia calcification (FIBGC) is a rare autosomal dominant neurodegenerative disease, the main clinical signs of which are parkinsonism, cognitive deterioration and/or psychiatric troubles. Familial forms are rare. The underlying basis is not known. We performed detailed neurological, neuropsychological, brain CT scans and MRI evaluations in 15 patients of a large FIBGC family. Three patients also underwent a (18)FDG-PET scan study not previously performed in patients with FIBGC. Basal ganglia calcifications were present in 8 individuals, 3 of which had schizophrenia-like psychosis, cognitive and/or extrapyramidal signs. The mean age at disease onset was 34.0+/-3.6 years. Two patients had moderate executive dysfunction, whereas the proband had more severe dementia. (18)FDG uptake was significantly reduced in striatal or cortical areas, including the precuneus, posterior cingulate and superior temporal gyri. This study shows that calcifications and striatal neuronal degeneration can occur independently, and that functional changes in cortical areas can be observed early in FIBGC. Hypometabolism in the precuneus and posterior cingulate gyrus, which are involved in episodic memory processing, could be responsible for the episodic memory deficit found in the patients. Whether the underlying mechanism involves a neuronal loss or a functional alteration remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17481663     DOI: 10.1016/j.jns.2007.03.017

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  PDGFB partial deletion: a new, rare mechanism causing brain calcification with leukoencephalopathy.

Authors:  Gaël Nicolas; Anne Rovelet-Lecrux; Cyril Pottier; Olivier Martinaud; David Wallon; Louis Vernier; Gérard Landemore; Françoise Chapon; Carol Prieto-Morin; Elisabeth Tournier-Lasserve; Thierry Frébourg; Dominique Campion; Didier Hannequin
Journal:  J Mol Neurosci       Date:  2014-03-07       Impact factor: 3.444

Review 2.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

Review 3.  Cerebral correlates of psychotic syndromes in neurodegenerative diseases.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

4.  Ossified blood vessels in primary familial brain calcification elicit a neurotoxic astrocyte response.

Authors:  Yvette Zarb; Ulrike Weber-Stadlbauer; Daniel Kirschenbaum; Diana Rita Kindler; Juliet Richetto; Daniel Keller; Rosa Rademakers; Dennis W Dickson; Andreas Pasch; Tatiana Byzova; Khayrun Nahar; Fabian F Voigt; Fritjof Helmchen; Andreas Boss; Adriano Aguzzi; Jan Klohs; Annika Keller
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

Review 5.  Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features.

Authors:  Giulia Donzuso; Giovanni Mostile; Alessandra Nicoletti; Mario Zappia
Journal:  Neurol Sci       Date:  2019-07-02       Impact factor: 3.307

Review 6.  Basal ganglia calcification as a putative cause for cognitive decline.

Authors:  João Ricardo Mendes de Oliveira; Matheus Fernandes de Oliveira
Journal:  Dement Neuropsychol       Date:  2013 Apr-Jun

7.  SWI and phase imaging reveal intracranial calcifications in the P301L mouse model of human tauopathy.

Authors:  Ruiqing Ni; Yvette Zarb; Gisela A Kuhn; Ralph Müller; Yankey Yundung; Roger M Nitsch; Luka Kulic; Annika Keller; Jan Klohs
Journal:  MAGMA       Date:  2020-05-28       Impact factor: 2.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.